PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS

Adverse effects of antiepileptic drugs including cutaneous reactions may not only affect the result of treatment and quality of life, but can also be fatal if severe. Skin rash is more likely to occur during the first few months of treatment. The objective of this study was description of skin rashe...

Full description

Bibliographic Details
Main Authors: M. Ghaffarpour, S. S. Hejazie, M. H. Harirchian, H. Pourmahmoodian
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-02-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/2959
_version_ 1818240513121189888
author M. Ghaffarpour
S. S. Hejazie
M. H. Harirchian
H. Pourmahmoodian
author_facet M. Ghaffarpour
S. S. Hejazie
M. H. Harirchian
H. Pourmahmoodian
author_sort M. Ghaffarpour
collection DOAJ
description Adverse effects of antiepileptic drugs including cutaneous reactions may not only affect the result of treatment and quality of life, but can also be fatal if severe. Skin rash is more likely to occur during the first few months of treatment. The objective of this study was description of skin rashes in users of four antiepileptic drugs. We identified skin rashes of phenytoin, carbamazepine, sodium valproate and lamotrigine in a prospective descriptive cross sectional study in 1086 cases. Patients suffering from skin diseases, systemic illness with cutaneous presentations, radiation or drug–induced rash from non antiepileptic drugs and patients unwilling to be examined monthly were excluded. All the cases were followed for 6 months. Skin rashes occurred in 2.1% (23/1086) of patients. Twelve patients were male and the remaining 11 were female. The age of patients ranged from 8 to 71 (mean 24) years. Maculopapular rash and Stevens Johnson’s syndrome formed 56.5% (13/23) and 30.4% (7/23) of symptomatic cases, respectively. Toxic epidermal necrolysis, erythema multiform and psoriatic dermatitis each were detected in 4.3% (1/23) of patients. The interval between the beginning of antiepileptic as monotherapy or an add-on drug and skin rash presentation was from 3 to 45 (mean 13)days. Combination therapy was found to increase the incidence of rash, but dosage of drug did not show such effect. Special attention to skin rash in the first month of therapy and monotherapy instead of polytherapy is recommended.
first_indexed 2024-12-12T13:14:38Z
format Article
id doaj.art-9b88f99dd02f4fda8f8bebfb9e6e079b
institution Directory Open Access Journal
issn 0044-6025
1735-9694
language English
last_indexed 2024-12-12T13:14:38Z
publishDate 2005-02-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-9b88f99dd02f4fda8f8bebfb9e6e079b2022-12-22T00:23:27ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942005-02-01431PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS M. Ghaffarpour0 S. S. Hejazie1 M. H. Harirchian2 H. Pourmahmoodian3 Adverse effects of antiepileptic drugs including cutaneous reactions may not only affect the result of treatment and quality of life, but can also be fatal if severe. Skin rash is more likely to occur during the first few months of treatment. The objective of this study was description of skin rashes in users of four antiepileptic drugs. We identified skin rashes of phenytoin, carbamazepine, sodium valproate and lamotrigine in a prospective descriptive cross sectional study in 1086 cases. Patients suffering from skin diseases, systemic illness with cutaneous presentations, radiation or drug–induced rash from non antiepileptic drugs and patients unwilling to be examined monthly were excluded. All the cases were followed for 6 months. Skin rashes occurred in 2.1% (23/1086) of patients. Twelve patients were male and the remaining 11 were female. The age of patients ranged from 8 to 71 (mean 24) years. Maculopapular rash and Stevens Johnson’s syndrome formed 56.5% (13/23) and 30.4% (7/23) of symptomatic cases, respectively. Toxic epidermal necrolysis, erythema multiform and psoriatic dermatitis each were detected in 4.3% (1/23) of patients. The interval between the beginning of antiepileptic as monotherapy or an add-on drug and skin rash presentation was from 3 to 45 (mean 13)days. Combination therapy was found to increase the incidence of rash, but dosage of drug did not show such effect. Special attention to skin rash in the first month of therapy and monotherapy instead of polytherapy is recommended.https://acta.tums.ac.ir/index.php/acta/article/view/2959Antiepileptic drugsrashStevens Johnson’s syndrometoxic epidermal necrolysishypersensitivity syndrome
spellingShingle M. Ghaffarpour
S. S. Hejazie
M. H. Harirchian
H. Pourmahmoodian
PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
Acta Medica Iranica
Antiepileptic drugs
rash
Stevens Johnson’s syndrome
toxic epidermal necrolysis
hypersensitivity syndrome
title PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
title_full PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
title_fullStr PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
title_full_unstemmed PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
title_short PHENYTION, CARBAMAZEPINE, SODIUM VALPROATE AND LAMOTRIGINE INDUCED CUTANEOUS REACTIONS
title_sort phenytion carbamazepine sodium valproate and lamotrigine induced cutaneous reactions
topic Antiepileptic drugs
rash
Stevens Johnson’s syndrome
toxic epidermal necrolysis
hypersensitivity syndrome
url https://acta.tums.ac.ir/index.php/acta/article/view/2959
work_keys_str_mv AT mghaffarpour phenytioncarbamazepinesodiumvalproateandlamotrigineinducedcutaneousreactions
AT sshejazie phenytioncarbamazepinesodiumvalproateandlamotrigineinducedcutaneousreactions
AT mhharirchian phenytioncarbamazepinesodiumvalproateandlamotrigineinducedcutaneousreactions
AT hpourmahmoodian phenytioncarbamazepinesodiumvalproateandlamotrigineinducedcutaneousreactions